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The epithelial sodium channel (ENaC) constitutes the
rate-limiting step for sodium absorption across airway
epithelia, which in turn regulates airway surface liquid
(ASL) volume and the efficiency of mucociliary clear-
ance. This role in ASL volume regulation suggests that
ENaC activity is influenced by local factors rather than
systemic signals indicative of total body volume homeo-
stasis. Based on reports that ENaC may be regulated by
extracellular serine protease activity in Xenopus and
mouse renal epithelia, we sought to identify proteases
that serve similar functions in human airway epithelia.
Homology screening of a human airway epithelial cDNA
library identified two trypsin-like serine proteases
(prostasin and TMPRSS2) that, as revealed by in situ
hybridization, are expressed in airway epithelia. Func-
tional studies in the Xenopus oocyte expression system
demonstrated that prostasin increased ENaC currents
60–80%, whereas TMPRSS2 markedly decreased ENaC
currents and protein levels. Studies of primary nasal
epithelial cultures in Ussing chambers revealed that in-
hibition of endogenous serine protease activity with
aprotinin markedly decreased ENaC-mediated currents
and sensitized the epithelia to subsequent channel acti-
vation by exogenous trypsin. These data, therefore, sug-
gest that protease-mediated regulation of sodium ab-
sorption is a function of human airway epithelia, and
prostasin is a likely candidate for this activity.
The amiloride-sensitive epithelial sodium channel (ENaC)1
(1) constitutes the rate-limiting step of sodium transport across
many epithelia, including the kidney, colon, and lung (2). In the
kidney, the regulation of ENaC activity is necessary for the
proper maintenance of total body extracellular volume and
blood pressure and is responsive to systemic hormonal signals,
such as aldosterone and vasopressin. In the lung, regulated
ENaC activity is essential for the maintenance of airway sur-
face liquid (ASL) volume/depth. The physiologic importance of
the relationship between ENaC activity in airways and ASL
volume is highlighted by two disease states, cystic fibrosis (CF)
and pseudohypoaldosteronism type 1. In CF, the loss of func-
tional cystic fibrosis transmembrane conductance regulator
(CFTR) protein results in excessive ENaC activity (3, 4), so-
dium hyperabsorption (5), and ASL volume depletion (6). The
depletion of ASL volume, in turn, causes the overlying mucus
gel to collapse onto cilia and the cell surface, thus disrupting
mucociliary clearance (7). In contrast to CF, pseudohypoaldo-
steronism type 1 patients have mutations in genes encoding
ENaC subunits, which result in diminished sodium absorption,
increased ASL volume, and markedly accelerated rates of mu-
cociliary clearance (8). CF and pseudohypoaldosteronism type
1, therefore, provide striking evidence that regulated ENaC
activity is a prime determinant of ASL volume and mucociliary
function.
The regulation of ENaC has proven to be tissue-specific, and
many previously characterized mechanisms pertinent to ENaC
activity in the kidney may not be relevant in airway epithelia.
For example, dietary salt intake and circulating mineralocor-
ticoid levels modulate ENaC activity in the kidney but do not
affect ENaC function in airways (9). Similarly, while signals
that raise intracellular cAMP in the kidney (e.g. vasopressin)
increase ENaC currents by stimulating channel insertion into
the plasma membrane (10, 11), this second messenger pathway
has little effect on amiloride-sensitive currents in normal air-
ways (4). Finally, while patients with Liddle’s syndrome man-
ifest renal sodium hyperabsorption due to ENaC mutations
(12–14), they do not appear to have sodium hyperabsorption
across airway epithelia (15). Based upon these differences, we
speculate that 1) ENaC regulation is tissue-specific and 2) local
regulators responding to stimuli in the immediate channel
vicinity, rather than systemic signals, are likely to play a
dominant role in the lung.
Vallet et al. (16) identified one such candidate for the local
regulation of ENaC in 1997. These investigators cloned a tryp-
sin family serine protease, xCAP1 (channel-activating prote-
ase), from a Xenopus kidney epithelial cell line (A6) using a
functional complementation assay designed to detect activators
of ENaC in the Xenopus oocyte expression system. In this
assay, a 2–3-fold activation of ENaC was observed when xCAP1
was coexpressed with rat or Xenopus ENaC in oocytes. This
effect appeared to rely on extracellular xCAP1 protease activ-
ity, since incubation in media containing a serine protease
inhibitor (aprotinin) prevented ENaC activation. Northern
analyses identified message for xCAP1 in Xenopus tissues
where ENaC was also expressed, including the kidney, gut,
lung, and skin. They further showed that endogenous serine
protease activity regulated basal ENaC currents in the Xeno-
pus A6 renal epithelial cell line. As in studies of xCAP1 in
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oocytes, inhibition of extracellular serine protease activity with
aprotinin significantly diminished ENaC currents, whereas the
subsequent addition of exogenous trypsin rapidly increased
amiloride-sensitive sodium transport. The first mammalian
homologue of xCAP1 was identified in a mouse kidney cell line
(mpkCCDc14) by RT-PCR with degenerate primers (17). The
mouse homologue, mCAP1, increased amiloride-sensitive cur-
rents approximately 6-fold when coexpressed in Xenopus oo-
cytes. Aprotinin treatment of the mpkCCDc14 cell line to inhibit
endogenous serine protease activity again reduced amiloride-
sensitive currents.
The current study was designed to identify human serine
proteases expressed in the airway epithelia that may be impor-
tant regulators of ENaC activity. We used RT-PCR and cDNA
library screening techniques to search for sequences with ho-
mology to xCAP1 that are expressed by human tracheobron-
chial airway epithelial cells. Two separate clones were obtained
by these methods, which were identical to previously cloned
serine proteases, prostasin and TMPRSS2. The expression pat-
tern in the lung and functional effects on ENaC in Xenopus
oocytes were also tested. Finally, the importance of serine
protease activity for ENaC regulation in airway tissues was
examined using primary cultures of nasal airway epithelial
cells. Based on these data, we propose that prostasin is the
human homologue of xCAP1 and is involved in regulation of
ENaC activity in the lung.
EXPERIMENTAL PROCEDURES
Tissue Acquisition—Human nasal tissues were obtained from pa-
tients (mean age 42.8 years; range 19–58 years) undergoing rhinologic
procedures (e.g. turbinectomy). Upper and lower airway sections were
obtained from excess donor lung tissue during lung transplantation
procedures. All human tissue protocols were reviewed and approved by
the University of North Carolina Committee for the Protection of the
Rights of Human Subjects.
RNA Isolation, cDNA Library Preparation, PCR, and Library Screen-
ing—For RNA isolation and cDNA library preparation, trachea and
third to sixth generation airways were dissected and incised longitudi-
nally. Guanidine thiocyanate was applied directly to the surface epi-
thelium for 1–2 min, and the epithelial digest was removed by scraping
the surface with a glass slide. RNA was isolated by CsCl centrifugation,
and the integrity was confirmed by gel electrophoresis. Microscopic
examination of the tissue sections established that the superficial epi-
thelium was effectively removed from the underlying structure. A por-
tion of the isolated RNA was reverse transcribed, and a cDNA library
was constructed using the ZAP-cDNA Synthesis Kit (Stratagene) as per
the manufacturer’s instructions.
Four degenerate primers were designed, based on the amino acid
sequence of xCAP1 (outer 5, primer A (5-GACTATGGCGCGCCG-
GNAA(A/G)TT(T/C)CCNTGGCA(A/G)GT-3); outer 3, primer B (5-
GACTATTTAATTAATANACNCCNGGNC(G/T)(A/G)TTNGG-3); nested
5, primer C (5-GACTATGGCGCGCCACNGCNGCNCA(T/C)TG
(T/C)TT(T/C)CC-3); nested 3, primer D (5-GACTATTTAATTAACCN
(G/C)(A/T)(A/G)TCNCC(T/C)TG(A/G)CANGC-3)). After 40 cycles of
RT-PCR on human tracheobronchial RNA with primer combinations A-B,
A-D, C-B, and C-D, the PCR products were reamplified with the appro-
priate nested primer(s) for another 40 cycles of PCR, separated on a 1.2%
agarose gel, excised, purified, and ligated into the pCR2.1 vector with the
TA cloning kit (Invitrogen). Transformants were screened for inserts
following EcoRI digestion, and positive clones were sequenced by chain
termination automated sequencing.
A search for other relevant serine proteases was performed by
screening a human cDNA tracheobronchial epithelial library under low
stringency conditions with the 654-bp PCR product amplified using the
A-B primers. Library filters were incubated in prehybridization solu-
tion (50% formamide; 1 h) and then exposed to [32P]dCTP-labeled
probe (Random Primed labeling kit; Roche Molecular Biochemicals) in
hybridization solution (30% formamide; 37 °C) overnight. Filters were
then sequentially washed with 2 SSC, 0.1% SDS (2  15 min) and
with 0.5 SSC, 0.1% SDS (2  15 min) at 37 °C before exposing to
radiographic film overnight at 80 °C. Positive clones were released by
in vivo phage excision and identified by chain termination automated
sequencing. Further library screening with full-length probes encoding
xCAP1, prostasin, and TMPRSS2 was also performed under the iden-
tical conditions described above.
In Situ Hybridization—For in situ hybridization studies, tissues
were rapidly dissected from several regions (nasal, tracheal, and distal
lung) and snap frozen in OCT embedding compound, typically within 30
min of tissue resection. Distal lung sections were frozen on dry ice
following inflation with a 1:1 solution of OCT embedding compound and
phosphate-buffered saline. Thin sections (8 m) were cut by a
cryothome and mounted on glass slides. Tissue sections were fixed in
4% paraformaldehyde for 60 min, dehydrated through a graded alcohol
series, and stored desiccated at 20 °C until analyzed.
In situ hybridization was performed as previously described (18).
Fragments of the prostasin (bp 584–1039) and TMPRSS2 (bp 801–
1205) coding regions were subcloned into the pBluescript KS vector,
and 35S-UTP-labeled sense and antisense riboprobes were synthesized
by in vitro transcription with the appropriate RNA polymerase (Pro-
mega). Cryosections were air-dried, digested with proteinase K (10
g/ml; 30 min at 30 °C), and hybridized with the appropriate 35S-UTP-
labeled riboprobe (5  106 cpm in 50 l). After washing and RNase
treatment, tissue sections were coated with photographic emulsion
(Kodak NTB-2) and exposed for 5–14 days. Sections were then devel-
oped, counterstained with hematoxylin and eosin, and examined with a
Nikon microphot SA microscope connected to a 3CC-Chilled Camera
(Sony).
Functional Analysis in the Oocyte Expression System—cRNAs encod-
ing xCAP1, xENaC, and rENaCFLAG subunits; 2-adrenergic receptor
(cDNAs kindly provided by B. C. Rossier; Lausanne, Switzerland),
CFTR, prostasin, and TMPRSS2 were synthesized using SP6 or T7
RNA polymerase, analyzed for integrity with gel electrophoresis, and
quantitated by spectrophotometry. Healthy stage V-VI oocytes were
harvested from Xenopus laevis (Xenopus-1; Dexter, Michigan), defol-
liculated in collagenase type IA (1 mg/ml; Sigma) in calcium-free mod-
ified Barth’s solution, and maintained at 18 °C in modified Barth’s
solution (85 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.8 mM MgSO4, 0.4
mM CaCl2, 10 mM Hepes-NaOH (pH 7.2), 10 mg/liter penicillin, and 5
mg/liter streptomycin). Twenty-four hours after collagenase treatment,
oocytes were injected with 100 nl of the designated cRNA solution. To
test the effects of prostasin and TMRPSS2 on ENaC, a solution con-
taining equal amounts of  ENaC subunits (0.1–0.3 ng/subunit/
oocyte) and 0.75–2 ng/oocyte of the designated serine protease cRNA
was injected. To test the effect of TMPRSS2 on CFTR, oocytes were
injected with 10 ng of CFTR cRNA, 1 ng of 2-adrenergic receptor cRNA,
and 2 ng of TMPRSS2 cRNA.
Two-electrode voltage clamp experiments were performed 18–24 h
after the injection of cRNAs. Injected oocytes were perfused in frog
Ringer solution (containing 120 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2, 10
mM Hepes, pH 7.2), and currents were measured at a holding potential
of 100 mV. The difference in current measured in the presence and
absence of amiloride (10 M) defined ENaC currents. Substitution of
NaCl with 120 mM LiCl or KCl allowed the determination of ion selec-
tivity through ENaC in oocytes expressing ENaC with or without pros-
tasin. The effect of aprotinin (100 g/ml) or protease inihibitor mixture
(containing 4-(2-aminoethyl)benzenesulfonyl fluoride (100 M), pepsta-
tin A (1.5 M), trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane
(1.4 M), bestatin (4 M), leupeptin (2.2 M), and aprotinin (80 nM)) on
protease-mediated ENaC regulation were tested by adding these re-
agents either immediately after cRNA injection or 5 h before voltage
clamping oocytes. CFTR currents were measured in response to the
addition of isoproterenol (1 M) to oocytes expressing both CFTR and
the 2-adrenergic receptor.
Western blot analysis was used to examine prostasin protein expres-
sion in primary cultured airway epithelia and to test for the expression
of cRNAs injected in oocytes. Epithelial cell proteins were harvested
from 12-mm T-col inserts into 400 l of radioimmune precipitation
buffer (containing 150 mM NaCl, 50 mM Tris-Cl, 5 mM EDTA, 1%
Nonidet P-40, 0.5% deoxycholate, 0.5% Triton X-100, 1% SDS, 20 g/ml
phenylmethylsulfonyl fluoride, 5 g/ml leupeptin, 5 g/ml pepstatin A)
using a cell scraper and transferred to Eppendorf tubes. After briefly
vortexing, cells were incubated on ice for 30 min and then centrifuged
for 5 min at 14,000  g to removed insoluble material. Soluble cell
supernatant was collected and electrophoresed as described below.
Protein extracted from oocytes was isolated by serial passage
through 22- and 27-gauge needles in homogenization buffer (containing
77 mM NaCl, 10 mM Hepes, 1 mM MgCl2, pH 7.9, 20 g/ml phenylmeth-
ylsulfonyl fluoride, 5 g/ml leupeptin, 5 g/ml pepstatin A) on ice.
Centrifugation at 1000  g (4 °C) for 5 min separated yolk and pigment
granules from the remainder of the cell lysate. Further centrifugation
at 14,000  g for 20 min (4 °C) pelleted a microsomal fraction. Protein
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concentrations were measured using the Bradford method (Bio-Rad),
and 25–50 g of cell lysate or microsomal fraction was dissolved in
sample buffer and heated to 70 °C for 10 min prior to loading onto a
4–15% gradient acrylamide gel. After SDS-PAGE, proteins were trans-
ferred to a polyvinylidene difluoride membrane, blocked with 5% nonfat
dry milk, and incubated with primary antibody (either m2-FLAG (1:
1000; Sigma), a polyclonal antibody raised against the amino terminus
of -rENaC (N, 1:300; kindly provided by D. Rotin), or a polyclonal
antibody raised against prostasin) for 1 h at room temperature. Expo-
sure to secondary antibody (anti-mouse or -rabbit conjugated to horse-
radish peroxidase, 1:5000–10,000; Amersham Biosciences, Inc.) for 1 h
at room temperature followed by detection with ECL reagents (Amer-
sham Biosciences) was used to reveal immunoreactive proteins.
Ussing Chamber Experiments—Human nasal epithelial cells har-
vested from surgical tissue specimens were seeded at a density of 0.25 
106/cm2 on porous Snapwell-permeable supports (1.13-cm2 surface
area; Costar) coated with human placental collagen (50 g/cm2; Sigma
type VI) as previously described (19). Cell monolayers were grown at an
air-liquid interface in F-12/Dulbecco’s modified Eagle’s medium (1:1)
with 2% Ultraser-G. Cells were maintained in a humidified, 5% CO2,
37 °C incubator, and the culture medium was changed every other day.
Transepithelial resistance (Rt) and potential difference were monitored
daily, and cultures were used after 7 days of air-liquid interface
culture conditions.
Primary nasal epithelial air-liquid interface cultures exhibiting Rt 
150 cm2 were mounted in modified Ussing chambers (Physiologic
Instruments). The epithelium was bathed on both sides with warmed
(37 °C) Krebs-bicarbonate Ringer solution (containing 140 mM Na, 120
mM Cl, 5.2 mM K, 1.2 mM Ca2, 1.2 mM Mg2, 2.4 mM HPO4
2, 0.4 mM
H2PO4
, 25 mM HCO3
, and 5 mM glucose), circulated by gas lift with
95% O2, 5% CO2. The epithelial culture was voltage-clamped (Physio-
logical Instruments), and the short circuit current (Isc) was measured
and continuously recorded (Acquire version 1.0; Dataq Instruments).
After establishing a stable Isc, aprotinin (20 g/ml, 5 trypsin inhibi-
tory units/mg; Sigma) was added to the apical bath. After a 75-min
incubation, a brief exposure to amiloride (100 M; Sigma) was used to
measure the ENaC-mediated current. A 3-fold excess of trypsin (200
g/ml, 10,000 N-benzoyl-L-arginine ethyl ester units/mg; Sigma) on
the basis of activity (1 trypsin unit  9000 N-benzoyl-L-arginine ethyl
ester units) was then added, followed by a second exposure to amiloride.
Statistics—Results are expressed as the means 	 S.E. Amiloride-
sensitive currents in oocytes coexpressing ENaC with serine proteases
were normalized to currents measured in ENaC-expressing oocytes
studied from the same animal on the same day. Significance was de-
termined using an unpaired Student’s t test or analysis of variance for
the comparison of multiple sample groups.
RESULTS
Identification and Isolation of Two Human Serine Protease
cDNAs Expressed in Airways—Expressed genes with sequence
homology to xCAP1 were identified by RT-PCR of airway epi-
thelial RNA and by screening an airway cDNA expression
library. Using degenerate primers based upon the xCAP1
amino acid sequence, RT-PCR generated a 600-bp product
that was sequenced and found to be identical to a portion of the
human prostasin gene open reading frame. This PCR product
and the full-length prostasin and xCAP1 cDNA sequences were
then used to screen an airway epithelial expression library
under low stringency conditions in an attempt to identify other
sequences with significant homology. Using this approach, only
one other homologous clone was identified. This clone was
sequenced and found to be identical to another previously
cloned serine protease, TMPRSS2. Full-length prostasin and
TMPRSS2 clones were then generated by PCR using the TA
cloning kit (Invitrogen), and sequences were verified by chain
termination automated sequencing. Search of the GenBankTM
data bases revealed that prostasin is the nearest human ho-
mologue to xCAP1 and mCAP1 (41 and 76% amino acid iden-
tity, respectively). TMPRSS2, on the other hand, is signifi-
cantly less homologous to the mouse and Xenopus CAP1
sequences, having only about 16% identity (Fig. 1).
Expression of Prostasin and TMPRSS2 in Human Lung—To
evaluate the pattern of prostasin and TMPRSS2 expression in
the lung, we performed in situ hybridization on tissue speci-
mens obtained from the nose, upper airway, and distal lung
(Figs. 2 and 3). In these studies, we found strong expression of
both prostasin and TMPRSS2 in superficial epithelial cells
lining the nose, trachea, and distal airways. Although difficult
to assess because of the fine structural architecture, both pros-
tasin and TMPRSS2 appeared to be expressed at the alveolar
level, most notably at alveolar junctions in a “cornering pat-
tern” characteristic of type II pneumocytes. In addition to ro-
bust surface epithelial expression, message encoding prostasin
and TMPRSS2 was also pronounced in submucosal glands as-
sociated with nasal, tracheal, and bronchial tissues. Impor-
tantly, neither serine protease was observed in nonepithelial
tissues.
Functional Analysis of Prostasin and TMPRSS2 in Xenopus
Oocytes—To determine whether prostasin or TMPRSS2 could
regulate ENaC currents, we performed cRNA coexpression
studies in Xenopus oocytes. Current measured via two-elec-
trode voltage clamping 24 h after cRNA injection in the pres-
ence and absence of amiloride defined ENaC-mediated cur-
rents. Importantly, amiloride-sensitive currents were not
observed in control oocytes injected only with water, prostasin,
or TMPRSS2 (data not shown). Coexpression of prostasin
cRNA with either Xenopus or rat ENaC cRNA, however, led to
an 80% increase in rENaC-mediated currents (p 
 0.005; n 
73 oocytes/group from 10 frogs) and a 60% increase in xE-
NaC-mediated currents (p  0.02; n  28 oocytes/group from
three frogs) (Fig. 4A). We also measured the ability of xCAP1 to
activate ENaC in parallel groups of oocytes and observed a
similar magnitude of channel activation in xENaC-expressing
oocytes (p  NS; n  24 oocytes from three frogs) (Fig. 4A).
Interestingly, xCAP1 caused a significantly greater activation
of amiloride-sensitive currents in rENaC-expressing oocytes
than did prostasin (p 
 0.01; n  46 oocytes from seven frogs)
(Fig. 4A). We confirmed that the activation of ENaC by pros-
tasin required extracellular serine protease activity by incu-
bating oocytes in aprotinin (100 g/ml) for 5 h prior to meas-
urement of amiloride-sensitive currents. This maneuver
completely prevented ENaC activation by prostasin (p 
 0.001;
n  7 oocytes/group) (Fig. 4B). Aprotinin treatment also re-
duced ENaC currents in oocytes expressing ENaC alone (p 

0.005; n  7 oocytes/group)(Fig. 4B), suggesting that an endog-
enous protease with the ability to activate ENaC may also be
expressed in oocytes. The addition of trypsin (200 g/ml) after
aprotinin treatment increased ENaC currents 5-fold within 3
min in both groups (p 
 0.001; n  7 oocytes/group) (Fig. 4B),
demonstrating that ENaC channels remained sensitive to pro-
tease activation after aprotinin treatment.
We tested whether coexpression of prostasin with rENaC
changed the electrophysical properties of the channel by deter-
mining the amiloride-sensitive current carried by Na, Li, or
K in the presence and absence of prostasin. No significant
amiloride-sensitive current was measured at 100 mV when
K was the only monovalent cation in the extracellular bath
either in the presence or absence of prostasin. In agreement
with data from native tissues, Li was conducted to a greater
extent than Na in both groups of oocytes. However, we ob-
served a trend toward a lower Li/Na conductivity ratio in
oocytes coexpressing prostasin with ENaC (1.39 	 0.02 versus
1.60 	 0.10; p  0.13, n  5 per group).
In contrast to prostasin, coexpression of TMPRSS2 with
ENaC led to a marked reduction in amiloride-sensitive cur-
rents (Fig. 5A). The effect was directly proportional to the
amount of TMPRSS2 cRNA that was injected in each oocyte,
and obliteration of ENaC currents was achieved with relatively
small amounts of injected TMPRSS2 cRNA (2 ng/oocyte) (Fig.
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5B). To test whether this affect was due to a generalized inhi-
bition of protein translation, TMPRSS2 was coexpressed with
CFTR and the 2-adrenergic receptor (Fig. 5C). In these exper-
iments, CFTR currents stimulated by isoproterenol were not
significantly reduced compared with CFTR currents measured
in the absence of TMPRSS2.
Reduced ENaC currents may also be the result of a specific
effect on ENaC protein levels. We prepared yolk-depleted ly-
FIG. 1. Amino acid alignment of relevant serine proteases. Sequences of human prostasin, mouse CAP1, Xenopus CAP1, and human
TMPRSS2 are aligned with identical residues in boldface type and similar residues shaded. The nonhomologous amino terminus of TMPRSS2
(residues 1–207) is not shown.
FIG. 2. In situ hybridization of pros-
tasin in nasal, tracheal, and distal
lung tissues. The bright field image
(H&E) of each frozen section (left) and
dark-field images of sections exposed to
antisense (center) and sense (right)
mRNA probes are shown. Submucosal
glands (G), bronchioles (B), and blood ves-
sels (V) are labeled accordingly.
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sates and microsomal fractions from oocytes expressing rENaC
with or without TMPRSS2 and measured ENaC protein ex-
pression by Western blot analysis. In these experiments, ex-
pression of TMPRSS2 resulted in a virtually complete loss of
ENaC protein (Fig. 5D). In contrast to the observations with
prostasin, the inhibition of ENaC currents by TMPRSS2 was
not prevented by the addition of aprotinin (200 g/ml) or a
mixture of protease inhibitors added to the oocyte bathing
media immediately after cRNA injection (data not shown),
suggesting that channel inactivation/degradation did not occur
after ENaC and TMPRSS2 had reached the plasma membrane.
Effect of Aprotinin and Trypsin on Human Airway Tissues—
Well differentiated primary nasal airway epithelial cultures
were mounted in modified Ussing chambers to examine ENaC
regulation by endogenous serine proteases (Fig. 6, A and B).
The addition of aprotinin (10 M) to the apical bath resulted in
a marked inhibition of the Isc over 75 min, compared with
vehicle controls (p  0.01). The subsequent addition of trypsin
led to a rapid increase in Isc in tissues that had been pretreated
with aprotinin (p 
 0.001). Importantly, nearly the entire Isc
FIG. 3. In situ hybridization of TM-
PRSS2 in nasal, tracheal, and distal
lung tissues. The bright field image
(H&E) of each frozen section (left) and
dark-field images of sections exposed to
antisense (center) and sense (right)
mRNA probes are shown. Submucosal
glands (G), bronchioles (B), and blood ves-
sels (V) are labeled accordingly.
FIG. 4. Functional analysis of prostasin in Xenopus oocytes. A,
oocytes were injected with cRNA encoding Xenopus (n  24 oocytes from
three animals per condition) or rat (n  46 oocytes from at least seven
animals per condition) ENaC subunits (0.3 ng/subunit) in the absence
(open bars) or presence of human prostasin (2 ng) (gray bars) or xCAP1
(2 ng) (black bars), and amiloride-sensitive currents were measured. B,
oocytes were injected with cRNA encoding rENaC in the absence (open
bars) or presence of human prostasin (gray bars). Amiloride-sensitive
currents were measured after no treatment (left panel; n  7 oocytes/
group) and 5 h after exposing oocytes to aprotinin (100 g/ml) (center
panel; n  7 oocytes/group). The subsequent effect of trypsin (200
g/ml) on amiloride-sensitive currents in aprotinin-pretreated eggs was
also tested (right panel; n  7 oocytes/group). *, p 
 0.05 versus control.
FIG. 5. Functional analysis of TMPRSS2 in Xenopus oocytes. A,
oocytes were injected with cRNA encoding rENaC subunits (1 ng cRNA)
in the absence (open bars; n  65) or presence (black bars; n  14) of
TMPRSS2 (2 ng of cRNA), and amiloride-sensitive currents were meas-
ured. B, dose response of TMPRSS2 on ENaC-mediated currents (*, p 

0.001 between groups by analysis of variance; n  14 oocytes/group). C,
CFTR (10 ng cRNA) and the 2-adrenergic receptor (1 ng cRNA) were
coinjected in the presence or absence of TMPRSS2 (2 ng) (p  NS; n 
7 oocytes/group). D, Western analysis, using polyclonal antibody di-
rected against the  subunit of rat ENaC.
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was amiloride-sensitive. These data suggest that endogenous
serine proteases had an activating influence on ENaC in pri-
mary cultured cells. We therefore determined whether prosta-
sin and TMPRSS2 mRNAs were expressed in this cell culture
system using RT-PCR (Fig. 6C). As shown, both serine pro-
teases were expressed in identical tissues to those used for
Ussing chamber experiments. Prostasin protein was also
readily detected in primary culture airway epithelia (Fig. 6D),
although antibodies raised against TMPRSS2 proved not to be
useful due to poor specificity.
DISCUSSION
The regulation of ENaC activity is tightly linked to ASL
volume and mucociliary clearance and therefore is a key deter-
minant of lung health. ENaC regulation appears to be tissue-
specific, and in the lung it may rely upon regulators of ENaC
that are responsive to local stimuli. The discovery of an extra-
cellular serine protease that is expressed on the lumen of
Xenopus (16) and mouse (17) renal epithelia and can regulate
ENaC activity raised the possibility that a similar mechanism
of ENaC regulation might exist in the human lung.
In the present study, we sought to determine whether a
channel-activating serine protease was expressed in human
airway epithelia. Using RT-PCR and cDNA library screening
techniques, we identified two candidate serine proteases, pros-
tasin and TMPRSS2, that were expressed in human tracheo-
bronchial epithelial cells. Sequence analysis of prostasin and
TMPRSS2 showed that both belong to the trypsin family of
serine proteases (peptidase family S1). Comparison of prosta-
sin and TMPRSS2 with xCAP1 and mCAP1 reveals consider-
able similarity between prostasin and the CAP1 genes and
significantly less similarity between TMPRSS2 and either of
the other sequences.
Interestingly, both prostasin and TMPRSS2 are predicted to
be plasma membrane proteins, with protease catalytic domains
located in the extracellular compartment (20, 21). The protein
structure of prostasin predicts an amino-terminal signal pep-
tide (residues 1–29), an extracellular trypsin-like protease do-
main, and a COOH-terminal transmembrane domain (residues
320–340). Yu et al. (20) further deduced that prostasin purified
from seminal fluid was a heterodimer, formed by cleavage of a
precursor prostasin polypeptide into a 12-amino acid light
chain (residues 33–44) and 299-amino acid heavy chain (resi-
dues 45–322). Secretion into the prostatic lumen, therefore,
required cleavage between the heavy chain domain and the
COOH-terminal transmembrane domain. Further work has
shown that prostasin, like xCAP1, is a glycosylphosphatidyli-
nositol-anchored protein that may either be secreted or mem-
brane-bound (22). Consistent with our in situ hybridization and
library screening data, Yu et al. (20) detected prostasin mRNA
in the lung by Northern analysis as well as in other epithelia-
lined organs (prostate, liver, salivary gland, kidney, pancreas,
and colon). Although very high protein levels have been de-
tected in the prostate (23), its function in this and other tissues
remains unknown.
In contrast to CAP1 and prostasin, the TMPRSS2 sequence
predicts a type II transmembrane protein without a recogniz-
able signal peptide, an amino-terminal cytoplasmic domain
(residues 1–84), a transmembrane domain (residues 85–105),
and a complex extracellular structure (residues 106–492) that
not only includes a serine protease domain but also low density
lipoprotein receptor A and scavenger receptor cysteine-rich
domains (21). Low density lipoprotein receptor A and scavenger
receptor cysteine-rich motifs are thought to mediate low den-
sity lipid/Ca2 binding and the binding of extracellular mole-
cules to the cell surface, respectively. Because TMPRSS2 may
be up-regulated in the basal cell layer of malignant prostate
cancers, a role in carcinogenesis has been proposed, although
its function in normal cellular physiology is not yet known (24).
Once again, consistent with our data, other investigators have
detected the expression of TMPRSS2 in the lung at the mRNA
level (21, 24).
Functional testing of prostasin and TMPRSS2 in Xenopus
oocytes revealed opposite effects on ENaC-mediated Na cur-
rents. Prostasin, like xCAP1, activated amiloride-sensitive
Na currents in oocytes. Previous studies have shown that
xCAP1 and exogenous trypsin activate ENaC without an asso-
FIG. 6. Effect of aprotinin and trypsin on short circuit current
(Isc) in primary nasal epithelial cells. Cells were mounted in mod-
ified Ussing chambers and exposed to aprotinin (20 g/ml) or vehicle for
75 min; all cells were then exposed to trypsin (200 g/ml). A, represent-
ative tracing of the described experiment. B, summary data from three
tissue donors (n  9 tissues), expressed as the change in Isc between the
addition of aprotinin (black bars) or vehicle (open bars) and 75 min
later; the change in Isc in response to trypsin, measured 5 min after its
addition in aprotinin-treated (black bars) and -untreated (open bars)
tissues; and the change in Isc after amiloride, added after trypsin. C,
expression of prostasin and TMPRSS2 in primary nasal epithelial cell
cultures was confirmed using RT-PCR. Prostasin primers were used in
lanes 1–3; TMPRSS2 primers were used in lanes 4–6. Lanes 1 and 4
were reactions performed in the absence of reverse transcriptase; lanes
2 and 5 were performed cDNA-positive controls; lanes 3 and 6 were
performed with mRNA isolated from primary nasal epithelial cell cul-
tures. D, prostasin protein expression was confirmed by Western blot
analysis. Lanes 1 and 2 contain oocyte microsomal fractions made from
uninjected (lane 1) and prostasin-expressing oocytes (lane 2) and are
included as controls. Lane 3 is empty, and lane 4 was loaded with
primary airway epithelial cell lysate (20 g).
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ciated increase in the number of surface channels or change in
single channel conductance, thereby implicating a marked in-
crease in channel open probability (16, 17, 25). The mechanism
underlying this change in channel activity is unknown, but it
could reflect a direct effect of the protease on ENaC or may
involve intermediary proteins. In this latter scenario, one may
envision either the proteolytic destruction/alteration of an
ENaC-inhibiting molecule or the proteolytic activation of a
separate channel-activating preprotein. We did observe a small
change in the relative conductance of lithium and sodium
through ENaC channels that were coexpressed prostasin, pos-
sibly suggesting a direct effect on the channel itself. Interest-
ingly, a similar change in ion selectivity was previously ob-
served after treating ENaC-expressing oocytes with trypsin
(25). Further studies are necessary to investigate these poten-
tial mechanisms.
In contrast, TMPRSS2 expression abolished ENaC-mediated
amiloride-sensitive Na currents in oocytes. Furthermore, TM-
PRSS2 expression also markedly reduced cellular ENaC pro-
tein levels. Given the absence of an effect of TMPRSS2 on
CFTR and 2-adrenergic receptor expression, oocyte health and
the capacity to translate cRNA into protein were intact in
oocytes expressing TMPRSS2. We also ruled out the simple
explanation that oocytes preferentially express CFTR  TM-
PRSS2  ENaC through CFTR/ENaC coexpression studies. In
these experiments, CFTR coexpression did not reduce ENaC-
mediated currents (prior to CFTR activation with cAMP), nor
did it reduce total ENaC protein levels (data not shown). Chan-
nel proteolysis by TMPRSS2 may instead be responsible for the
observed decrease in ENaC activity. The site of proteolysis is
likely to be in the intracellular compartment, because the ad-
dition of protease inhibitors to the bathing media did not alter
the observed inhibition of ENaC currents. Certainly, the major
question to be raised by these observations is whether TM-
PRSS2 proteolysis of ENaC is physiologically relevant. Because
airway epithelia have ENaC currents that are stimulated by
endogenous serine protease activity (see below), it seems likely
that ENaC inhibition by TMPRSS2 is not a dominant regula-
tory mechanism. These data do suggest that not all trypsin-like
serine proteases are able to stimulate ENaC and/or that cellu-
lar compartmentalization of the channel and protease may
contribute to specificity.
Using well differentiated airway epithelia, aprotinin and
trypsin were used as probes of the endogenous extracellular
serine protease activity in human airway epithelia. Under the
conditions used in these experiments, sodium currents through
ENaC are substantial and represent the dominant basal ion
transport activity (Fig. 6, A and B). Treatment with apical
aprotinin led to a gradual but clear decline in the amiloride-
sensitive Isc over 75 min. The subsequent addition of excess
trypsin to the apical chamber caused an immediate increase in
Isc, which was entirely amiloride-sensitive. This trypsin re-
sponse was only observed in aprotinin-pretreated tissues.
These data, therefore, demonstrate that an endogenous serine
protease is present, activates ENaC, and is fully effective at
endogenously expressed levels, as evidenced by the observation
that trypsin does not activate ENaC in the absence of aprotinin
pretreatment (Fig. 6B). Based upon its homology to CAP1,
airway expression, and these functional studies, we speculate
that prostasin, and not TMPRSS2, is likely to be a serine
protease relevant to ENaC regulation in airway epithelia. It is
possible, however, that other serine proteases, not detected by
our library screening experiments, may also contribute to reg-
ulation of ENaC in the human airway. In addition, while ENaC
is thought to be the dominant amiloride-sensitive pathway in
airway epithelia, we have not ruled out a serine protease effect
on other amiloride-sensitive, electrogenic pathways (e.g. cyclic
nucleotide gated channels (26)), which could contribute to our
experimental results.
With the identification of this novel regulatory pathway
come additional questions regarding the regulation of prostasin
activity in airways. Because airway surfaces are in direct com-
munication with inspired air, ASL is subject to fluctuations in
ionic strength and pH. One may envision that the catalytic
activity of prostasin and ultimately the activity of ENaC may
be regulated by changes such as these in the local milieu.
Another possibility is that the total amount of prostasin avail-
able to regulate ENaC might also be regulated acutely. As
shown by Yu et al., prostasin is not only cell-associated but is
also secreted by prostatic epithelial cells (23). Because we have
shown that airway submucosal glands also contain high levels
of prostasin message, it is possible that signals responsible for
gland secretion in airways might also lead to prostasin secre-
tion in airways populated by submucosal glands (i.e. proximal,
cartilaginous airways). In this manner, both surface-associated
and secreted prostasin may contribute to ENaC regulation.
Finally, because the stoichiometry of ENaC channel subunits
may vary in different lung regions (18, 27), it is also possible
that the impact of serine proteases on sodium absorption may
vary in different lung regions.
Further regulation of prostasin may also occur via endoge-
nous serine protease inhibitors in airways. In fact, in most
tissues that express a serine protease, a protease inhibitor is
also expressed to prevent uncontrolled tissue proteolysis. Of
note, a serine protease inhibitor termed placental bikunin was
recently cloned based on homology with aprotinin, is expressed
in lung, and has the potential to be either a membrane-associ-
ated or secreted protein (28, 29). Although we did not observe
further activation of ENaC by exogenous trypsin without apro-
tinin pretreatment in Ussing chambers (suggesting the ab-
sence of an endogenous protease inhibitor), failure to observe
this interaction may reflect massive dilution (4 ml/cm2) of a
soluble inhibitor in this experimental system, which is not
representative of the protease/inhibitor balance present under
thin liquid ASL conditions. Whether or not bikunin or another
relevant serine protease inhibitor is present on apical mem-
branes or in the airway lumen remains to be determined.
In summary, our data show that ENaC expressed in airway
epithelial cells is regulated by serine protease activity located
in the extracellular compartment. We propose that prostasin is
a relevant protease involved in this process and appears to be
the human homologue of the CAP1 gene. It is possible that
prostasin may be able to mediate ENaC regulation in response
to changes in the channel’s immediate microenvironment. Fu-
ture studies will focus on the mechanisms underlying channel
activation by prostasin and the larger issue of ENaC regulation
in airways.
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